5 hours Sanofi, Regeneron’s Dupixent Gets FDA Approval for COPD Zacks
Sanofi and Regeneron’s Dupixent becomes the first biologic treatment approved for COPD in the United States.
Regeneron Pharma (REGN) · U.S.
Sanofi and Regeneron’s Dupixent becomes the first biologic treatment approved for COPD in the United States.
Regeneron Pharma (REGN) · U.S.